JP2023036560A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023036560A5 JP2023036560A5 JP2022139117A JP2022139117A JP2023036560A5 JP 2023036560 A5 JP2023036560 A5 JP 2023036560A5 JP 2022139117 A JP2022139117 A JP 2022139117A JP 2022139117 A JP2022139117 A JP 2022139117A JP 2023036560 A5 JP2023036560 A5 JP 2023036560A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- additive
- additive according
- cryopreservation solution
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000654 additive Substances 0.000 claims 13
- 230000000996 additive effect Effects 0.000 claims 13
- 229920000642 polymer Polymers 0.000 claims 10
- 150000001413 amino acids Chemical class 0.000 claims 9
- 238000005138 cryopreservation Methods 0.000 claims 8
- 239000000243 solution Substances 0.000 claims 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 239000006143 cell culture medium Substances 0.000 claims 3
- 238000003018 immunoassay Methods 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 238000007710 freezing Methods 0.000 claims 2
- 230000008014 freezing Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 1
- 230000002528 anti-freeze Effects 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000002981 blocking agent Substances 0.000 claims 1
- 239000002577 cryoprotective agent Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 125000004185 ester group Chemical group 0.000 claims 1
- 125000001033 ether group Chemical group 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000002220 organoid Anatomy 0.000 claims 1
- 230000003204 osmotic effect Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- 229940124272 protein stabilizer Drugs 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 125000005156 substituted alkylene group Chemical group 0.000 claims 1
- 239000013076 target substance Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (23)
・・・一般式(1)
・・・一般式(2)
・・・一般式(3)
(一般式(1)~(3)中の、Aはアミノ酸残基、XおよびYは、それぞれ独立してOまたはNH、R1はアルキレン基、R2はアルキレン基、1つ以上の水素原子がヒドロキシル基で置換されたアルキレン基、フェニレン基、エステル基、エーテル基、ウレタン結合、アミド結合、またはこれらの組み合わせから構成される非イオン性の2価の基を示す。) The additive according to claim 1 or 2, wherein the amino acid-based polymer (A) has at least one of the structural units represented by the following general formulas (1) to (3).
...General formula (1)
...General formula (2)
...General formula (3)
(In general formulas (1) to (3), A is an amino acid residue, X and Y are each independently O or NH, R1 is an alkylene group, R2 is an alkylene group, and one or more hydrogen atoms are hydroxyl groups. Indicates a nonionic divalent group consisting of a substituted alkylene group, phenylene group, ester group, ether group, urethane bond, amide bond, or a combination thereof.)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021142896 | 2021-09-02 | ||
JP2021142896 | 2021-09-02 | ||
JP2021163797 | 2021-10-05 | ||
JP2021163797 | 2021-10-05 | ||
JP2021173568 | 2021-10-25 | ||
JP2021173568 | 2021-10-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023036560A JP2023036560A (en) | 2023-03-14 |
JP2023036560A5 true JP2023036560A5 (en) | 2024-03-28 |
Family
ID=85508492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022139117A Pending JP2023036560A (en) | 2021-09-02 | 2022-09-01 | Additive for protein or cells |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2023036560A (en) |
-
2022
- 2022-09-01 JP JP2022139117A patent/JP2023036560A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mazur | Principles of cryobiology | |
CN112142870A (en) | Preparation, raw materials, products and application of photo-coupling synergetic cross-linked hydrogel material | |
CN102246742B (en) | Biological tissue fixing agent and preparation method thereof | |
EP3316684B1 (en) | Method for the cryopreservation of cells for therapeutic purposes | |
CN101485303A (en) | Exfoliated cell preservative fluid | |
CN104010487A (en) | Use of synthetic janus particles for preventing or reducing crystal growth | |
CN102076345A (en) | Liquid composition comprising cisplatin-coordinating compound | |
KR102661728B1 (en) | polyalkoxy aliphatic compounds | |
CN111789109A (en) | Amino acid cryopreservation liquid and preparation method thereof | |
CN111793108B (en) | Application of cryopreservation liquid containing peptide compounds in organ and tissue cryopreservation | |
JP2002125693A (en) | Cell extract composition for synthesizing cell-free protein | |
Gao et al. | Development of icephilic ACTIVE glycopeptides for cryopreservation of human erythrocytes | |
JP2018531294A6 (en) | Polyalkoxy aliphatic compounds | |
WO2016076317A1 (en) | Agent for preserving biological component, and method for recovering biological component | |
JP2023036560A5 (en) | ||
CN106860871A (en) | A kind of preparation method of carboxymethyl chitosan pH sensitive aqueous gel pharmaceutical carriers | |
KR20140057192A (en) | Compositions and methods for stabilizing susceptible compounds | |
CN111789099B (en) | Application of cryopreservation liquid containing peptide compounds in cryopreservation of oocytes or embryos | |
CN111789100A (en) | Application of DMSO-free cryopreservation solution in cryopreservation of oocytes or embryos | |
JP6711424B2 (en) | Cell culture gel composition and method for producing the same, cell culture method and cell culture substrate | |
CN111789102B (en) | Application of thawing solution in thawing frozen and preserved oocyte or embryo | |
AU2020256873B2 (en) | Thawing fluid, preparation method therefor and use thereof | |
CN111789103B (en) | Thawing solution for cryopreservation and thawing method | |
US20220192179A1 (en) | Biomimetic ice-inhibiting material and cryopreservation solution comprising same | |
WO2023162065A1 (en) | Biological sample preservative, production method of biological sample preservative, preservation method of biological sample, and kit for preserving biological sample |